Eligibility required diary-confirmed perimenstrual attacks in ≥2 of 3 cycles and excluded chronic migraine and certain aura syndromes, strengthening interpretability for episodic menstrual patterns.
Data show that commercially and Medicaid-insured children with chronic or immunocompromising conditions incur 2- to 3-fold higher costs. A retrospective cohort study using the Merative MarketScan ...
AD109 produced statistically significant AHI improvement versus placebo at 26 weeks (treatment difference –4.0 events/hour; ...
Large-scale linkage analyses suggest prenatal SARS‑CoV‑2 exposure is not associated with most neurodevelopmental or neurological diagnoses in early childhood. Restricting to pre–March 2022 births ...
Cox-adjusted analyses associated ≥1 year HRT use with reduced all-cause dementia (HR 0.90) and Alzheimer disease (HR 0.84), ...
Vanessa Slowey lays the ground for where AI and automation are impacting pharmacy practice today and discusses what ...
Jesse Goodman, MD, MPH, director of the Center on Medical Product Access, Safety and Stewardship (COMPASS) and attending ...
FDA approved 40-mg and 50-mg BID leniolisib for APDS in children 4–11 years weighing ≥27 kg, representing the first ...
National claims data (>104 million adults) showed higher unadjusted GLP-1 use in SMI, but adjustment for indications and ...
Advanced respiratory support during acute hospitalization demonstrated the strongest pooled association with post-COVID-19 ...
The law of rhythm states, simply, that everything moves in a predictable cycle. Day follows night and seasons follow one ...
mRNA technology predates COVID-19 by more than a decade, and a protein-based alternative exists for patients who remain ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results